UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000042284 |
|---|---|
| Receipt number | R000048278 |
| Scientific Title | Open label, randomized controlled trial of the selective PPAR-alpha modulator; Pemafibrate to the effect of urinary protein suppression in CKD patients with dyslipidemia |
| Date of disclosure of the study information | 2020/11/01 |
| Last modified on | 2023/05/02 11:41:52 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2020/10/29 18:25:50 | ||
| 2 | Update | 2020/12/25 09:42:28 | Organization Division name Division name |
|
| 3 | Update | 2022/04/15 17:11:13 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2022/05/02 14:11:25 | Last follow-up date Date of closure to data entry Date trial data considered complete |
|
| 5 | Update | 2022/09/26 17:03:12 | Key secondary outcomes |
|
| 6 | Update | 2023/01/05 11:21:27 | Key exclusion criteria Key exclusion criteria |
|
| 7 | Update | 2023/01/05 11:23:08 | Last follow-up date |
|
| 8 | Update | 2023/05/02 11:41:52 | Recruitment status |
